Revolutionizing Drug Discovery: The Impact of Artificial Intelligence on Efficiency and Accuracy

Samuel Nzube Nwosu *

Department of Chemistry, Chukwuemeka Odumegwu Ojukwu University Uli, Anambra State, Nigeria.

*Author to whom correspondence should be addressed.


This study explores the transformative impact of Artificial Intelligence (AI) techniques, such as machine learning and deep learning, on drug discovery. It highlights the roles of Al in enhancing efficiency and precision, accelerating processes, refining outcomes, and managing large datasets. Real-world applications, like AI-driven drug screening and predictive modeling, are discussed, along with AI's potential for personalized drug discovery and ethical considerations. The current landscape and future implications of AI in drug discovery are examined, underscoring its ability to derive efficient and tailored treatment solutions.

Keywords: Artificial intelligence (AI), drug discovery, efficiency, personalized medicine, ethical consideration, implications

How to Cite

Nwosu, Samuel Nzube. 2024. “Revolutionizing Drug Discovery: The Impact of Artificial Intelligence on Efficiency and Accuracy”. Journal of Advances in Medical and Pharmaceutical Sciences 26 (6):56-63.


Download data is not yet available.


Wouters OJ, McKee M, Luyten J. Estimated research and development investment needed to bring a new medicine to market, 2009-2018. JAMA. 2020;323(9):844–853. DOI:10.1001/jama.2020.1166

Ish Khanna,Drug discovery in pharmaceutical industry: productivity challenges and trends,Drug Discovery Today. 2012;17(19)19–20:1088-1102,

ISSN 1359-6446

Hwang JY., Cho SW, Nam CW. Factors leading to the high failure rate in cancer drug development. Oncotarget. 2019;10(1) :1819-1830. DOI:10.18632/oncotarget.26619

Qureshi Rizwan. AI in drug discovery and its clinical relevance. Heliyon; 2023.

Hongming Chen, Ola Engkvist, Yinhai Wang, Marcus Olivecrona, Thomas Blaschke,The rise of deep learning in drug discovery,Drug Discovery Today. 2018; 23(6):1241-1250

ISSN 1359-6446.

Kandoi G, Acencio ML, Lemke N. Prediction of druggable proteins using machine learning and systems biology: A mini-review. Front. Physiol. 2015;6:366.

Shah P, Campbell P, Goh C, Abbani Y, Landreman A, Lovato A, Ebadollahi S. Machine learning in drug discovery: A review. Frontiers in Pharmacology. 2022;12:656498.

Topol EJ. AI in drug discovery and its clinical relevance. Nature Medicine, 2022; 28(1):28-33.

Zhavoronkov A, Polykovskiy D, Lau YS, Mall A, Bajic VB, Aladinskiy VA, Zhavoronkov I. Breaking Big Pharma's AI barrier: Insilico Medicine uncovers novel drug target in a week. Nature Communications. 2022;13(1) :1-8.

Borrero VM, da S, Voigt LR, de Fariña LO, de Lima IA. Nanotechnology Based Approaches to Enhance Therapeutic Efficacy of Chloroquine and Hydroxychloroquine– A Review. Journal of Advances in Medicine and Medical Research. 2024;36(3):46–71.


Honde BS, Rajendra KR. Structure based drug discovery, docking, modelling, synthesis and anticancer screening of some novel quinoline derivatives. Journal of Pharmaceutical Research International, 2011;33(62A):341–353. DOI: 10.9734/jpri/2021/v33i62A35384

Mak KK, Wong YH, Pichika MR. Artificial intelligence in drug discovery and development. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. 2023;28:1-38.

Farag A, Wang P, Ahmed M, Sadek H. Identification of FDA approved drugs targeting COVID-19 virus by Structure-Based Drug Repositioning ; 2020. Available:online:

Accessed on: 1 August 2021.

The speed of thought, by R. P. O’Reilly, published in Trends in Cognitive Sciences. 2001;5(7).

Gómez-Bombarelli R; Wei JN, Duvenaud D, Hernández-Lobato JM, Sánchez-Lengeling B, Sheberla D, Aguilera-Iparraguirre J, Hirzel TD, Adams RP, Aspuru-Guzik A. Automatic chemical design using a data-driven continuous representation of molecules. ACS Central Sci. 2018;4:268–276.

Damian Daniela, Tomaž Gams. Handling big data. In big data: An introduction to the emc data computing environment, edited by Jason R. Stamper. Boston: New Age International. 2015;1-24.

Jason Mark A, Doug Dutile. Big Data Storage. Scientific American. 2014;311 (5):44-49.

Parallel processing: A survey of mapreduce and spark by Justin Edwards and Andreas Paepcke, published in ACM Computing Surveys; 2016.

Managing big data in the cloud: A survey by J. Henke, published in IEEE Cloud Computing, 2014.- “ISO 8000: Standards for Data Quality” by DAMA International, published in 2017.

Deep learning for big data: A Survey by P. Kumar, published in IEEE Access; 2017.

SBSI. Good practices for computational analysis of high-throughput screening (HTS) Data in drug discovery, SBSI good practices committee; 2016.

McGinley L. How 23andMe is trying to turn a mountain of customer DNA data into a drug gold mine. The washington post; 2018. Available:

Drug Discovery & Development. Genentech. Available: This source provides an overview of Genentech’s approach to drug discovery and development, including the use of AI.

Leung LK, Zhang X, Lipinski CA. Applying machine learning to accelerate drug discovery: from target identification to clinical trials. Trends in Pharmacological Sciences, 2019;40(1):43-56. Available:

Brooks JR. Accelerating drug discovery and development with machine learning. Nature Reviews Drug Discovery, 2020;19 (5):311-325. Available:

Joseph CM., Karakutukcu N, Wilson, DH. Artificial intelligence: An engine for drug discovery; 2018.

Henslee JL, Denny JC, Topol EJ. Artificial intelligence in precision medicine. Nature Reviews Drug Discovery. 2019;18(12):845-854.


Pradhan A, Sajja PP. Precision medicine: the role of artificial intelligence; 2019.

Davies ML, Levinson H. Using generative AI to design proteins for the drug discovery pipeline. Cell Chemical Biology; 2023. Available:

Pfizer uses AI to speed up drug development, targeting potential COVID-19 vaccines; 2020.